药物对比
Linagliptin vs Dulaglutide
Linagliptin 与 Dulaglutide：口服DPP-4与每周一次GLP-1注射治疗2型糖尿病。比较A1c、减重、心血管获益、胃肠道影响及哪种更好。
此页面暂无可用的对比维度。
临床背景
This comparison arises when selecting between an oral DPP-4 inhibitor and an injectable GLP-1 agonist for type 2 diabetes, considering route, weight, and cardiovascular risk.
结论
Dulaglutide often delivers superior glycemic control, weight loss and CV outcomes versus Linagliptin, but the oral option may be preferred to avoid injections.
全部药物对比